跳至主要内容
临床试验/ACTRN12608000099325
ACTRN12608000099325招募中1 期

Effect of n-3 fatty acids on outcomes following hip fracture: a pilot study to investigate proof of concept, feasibility of recruitment and adherence to a 6 week fish oil intervention.

Dr Michelle Miller0 个研究点目标入组 30 人开始时间: 2008年2月21日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
60 Years 至 o limit(—)
性别
All

入选标准

  • 60 years or over
  • Hip fracture sufferers
  • No cognitive impairment according to the Mini Mental State Examination (MMSE score over 24/30)
  • At risk of subsequent weight loss according to the Simplified Nutrition Appetite Questionnaire (SNAQ score less than or =14/20)
  • Elevated CRP (6mg/L or more)
  • Able to consent

排除标准

  • Allergy to fish
  • Initiation of anti-inflammatory corticosteroids within the prior two weeks
  • Ingestion of n-3 fatty acid supplements within four weeks of study initiation
  • Life expectancy less than 6 weeks

研究者

相似试验